CNS and Chronic Drug Trials: New Cardiac Safety Requirements Webinar Replay
For long-term CNS drugs, blood pressure evaluation has become a critical consideration to establish the potential risk for stroke or other cardiovascular diseases. Blood pressure has also been implicated as a risk factor for neurological disease states as the brain is a frequent target of hypertension-induced damage. The link between blood pressure and brain pathology is mounting as studies have shown a correlation between blood pressure and CNS disorders such as dementia or Alzheimer’s, and a number of high-profile CNS drugs have been shown to have a significant impact on blood pressure.
Watch this webinar replay featuring experts from Clario as they discuss the cardiac safety requirements (BP & ECG) for CNS and chronically administered drugs.
The speakers will take a closer look at:
- The regulatory, scientific and technological evolutions in blood pressure and how these have impacted clinical trial design
- The strengths and challenges of blood pressure modalities will be assessed for various study types, with a focus on ABPM per the draft guidance
Subscribe to our newsletter
Stay up to date with the latest insights and best practices by subscribing to our newsletter. You’ll receive notifications whenever we publish new webinar replays, blog posts and other downloadable resources.